Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Dietary factors can protect against liver cancer development.

Koumbi L.

World J Hepatol. 2017 Jan 28;9(3):119-125. doi: 10.4254/wjh.v9.i3.119.

2.

The Association between Dietary Vitamin A and Carotenes and the Risk of Primary Liver Cancer: A Case-Control Study.

Lan QY, Zhang YJ, Liao GC, Zhou RF, Zhou ZG, Chen YM, Zhu HL.

Nutrients. 2016 Oct 11;8(10). pii: E624.

3.

Retinoid and carotenoid status in serum and liver among patients at high-risk for liver cancer.

Kataria Y, Deaton RJ, Enk E, Jin M, Petrauskaite M, Dong L, Goldenberg JR, Cotler SJ, Jensen DM, van Breemen RB, Gann PH.

BMC Gastroenterol. 2016 Feb 29;16:30. doi: 10.1186/s12876-016-0432-5.

4.

A New Method to Simultaneously Quantify the Antioxidants: Carotenes, Xanthophylls, and Vitamin A in Human Plasma.

Colmán-Martínez M, Martínez-Huélamo M, Miralles E, Estruch R, Lamuela-Raventós RM.

Oxid Med Cell Longev. 2015;2015:9268531. doi: 10.1155/2016/9268531.

5.

Urinary biomarkers of catechins and risk of hepatocellular carcinoma in the Shanghai Cohort Study.

Butler LM, Huang JY, Wang R, Lee MJ, Yang CS, Gao YT, Yuan JM.

Am J Epidemiol. 2015 Mar 15;181(6):397-405. doi: 10.1093/aje/kwu304.

6.

Activation of AMP-activated protein kinase by retinoic acid sensitizes hepatocellular carcinoma cells to apoptosis induced by sorafenib.

Ishijima N, Kanki K, Shimizu H, Shiota G.

Cancer Sci. 2015 May;106(5):567-75. doi: 10.1111/cas.12633.

7.

Effects of α-tocopherol and β-carotene supplementation on liver cancer incidence and chronic liver disease mortality in the ATBC study.

Lai GY, Weinstein SJ, Taylor PR, McGlynn KA, Virtamo J, Gail MH, Albanes D, Freedman ND.

Br J Cancer. 2014 Dec 9;111(12):2220-3. doi: 10.1038/bjc.2014.514.

8.

Association of serum α-tocopherol, β-carotene, and retinol with liver cancer incidence and chronic liver disease mortality.

Lai GY, Weinstein SJ, Albanes D, Taylor PR, Virtamo J, McGlynn KA, Freedman ND.

Br J Cancer. 2014 Nov 25;111(11):2163-71. doi: 10.1038/bjc.2014.365.

9.

Selenium for preventing cancer.

Vinceti M, Dennert G, Crespi CM, Zwahlen M, Brinkman M, Zeegers MP, Horneber M, D'Amico R, Del Giovane C.

Cochrane Database Syst Rev. 2014 Mar 30;(3):CD005195. doi: 10.1002/14651858.CD005195.pub3. Review.

10.

Non-alcoholic steatohepatitis and hepatocellular carcinoma: implications for lycopene intervention.

Ip BC, Wang XD.

Nutrients. 2013 Dec 27;6(1):124-62. doi: 10.3390/nu6010124. Review.

11.

Connexin-dependent gap junction enhancement is involved in the synergistic effect of sorafenib and all-trans retinoic acid on HCC growth inhibition.

Yang Y, Qin SK, Wu Q, Wang ZS, Zheng RS, Tong XH, Liu H, Tao L, He XD.

Oncol Rep. 2014 Feb;31(2):540-50. doi: 10.3892/or.2013.2894.

12.

Prediagnostic levels of serum one-carbon metabolites and risk of hepatocellular carcinoma.

Butler LM, Arning E, Wang R, Bottiglieri T, Govindarajan S, Gao YT, Yuan JM.

Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1884-93. doi: 10.1158/1055-9965.EPI-13-0497.

13.

HCC, diet and metabolic factors: Diet and HCC.

Montella M, Crispo A, Giudice A.

Hepat Mon. 2011 Mar;11(3):159-62.

14.

Hepatic metabolism of retinoids and disease associations.

Shirakami Y, Lee SA, Clugston RD, Blaner WS.

Biochim Biophys Acta. 2012 Jan;1821(1):124-36. doi: 10.1016/j.bbalip.2011.06.023. Review.

15.

Selenium for preventing cancer.

Dennert G, Zwahlen M, Brinkman M, Vinceti M, Zeegers MP, Horneber M.

Cochrane Database Syst Rev. 2011 May 11;(5):CD005195. doi: 10.1002/14651858.CD005195.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;3:CD005195.

16.

Association between alcohol consumption and cancers in the Chinese population--a systematic review and meta-analysis.

Li Y, Yang H, Cao J.

PLoS One. 2011 Apr 15;6(4):e18776. doi: 10.1371/journal.pone.0018776. Review.

17.

Targeting the inflammation in HCV-associated hepatocellular carcinoma: a role in the prevention and treatment.

Castello G, Costantini S, Scala S.

J Transl Med. 2010 Nov 3;8:109. doi: 10.1186/1479-5876-8-109. Review.

18.

Non-viral causes of hepatocellular carcinoma.

Blonski W, Kotlyar DS, Forde KA.

World J Gastroenterol. 2010 Aug 7;16(29):3603-15. Review.

19.

Viral hepatocarcinogenesis.

Tsai WL, Chung RT.

Oncogene. 2010 Apr 22;29(16):2309-24. doi: 10.1038/onc.2010.36. Review.

20.

Prospective evaluation of hepatitis B 1762(T)/1764(A) mutations on hepatocellular carcinoma development in Shanghai, China.

Yuan JM, Ambinder A, Fan Y, Gao YT, Yu MC, Groopman JD.

Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):590-4. doi: 10.1158/1055-9965.EPI-08-0966.

Items per page

Supplemental Content

Support Center